Publication:
Plasminogen Activator Inhibitor-1 Levels as an Indicator of Severity and Mortality for COVID-19

dc.contributor.authorBaycan Ö. F.
dc.contributor.authorBarman H. A.
dc.contributor.authorBölen F.
dc.contributor.authorAtıcı A.
dc.contributor.authorErman H.
dc.contributor.authorKorkmaz R.
dc.contributor.authorÇalım M.
dc.contributor.authorAtalay B.
dc.contributor.authorAçıksarı G.
dc.contributor.authorÇekmen M. B.
dc.contributor.authoret al.
dc.contributor.institutionauthorÇALIM, MUHITTIN
dc.date.accessioned2023-02-21T21:30:37Z
dc.date.available2023-02-21T21:30:37Z
dc.date.issued2023-02-01
dc.identifier.citationBaycan Ö. F., Barman H. A., Bölen F., Atıcı A., Erman H., Korkmaz R., Çalım M., Atalay B., Açıksarı G., Çekmen M. B., et al., "Plasminogen Activator Inhibitor-1 Levels as an Indicator of Severity and Mortality for COVID-19", NORTHERN CLINICS OF ISTANBUL = ISTANBUL KUZEY KLINIKLERI, cilt.10, sa.1, ss.1-9, 2023
dc.identifier.doi10.14744/nci.2022.09076
dc.identifier.endpage9
dc.identifier.issn2148-4902
dc.identifier.issue1
dc.identifier.pubmed36910430
dc.identifier.startpage1
dc.identifier.urihttps://northclinist.com/jvi.aspx?pdir=nci&plng=eng&un=NCI-09076&look4=
dc.identifier.urihttps://hdl.handle.net/20.500.12645/37094
dc.identifier.volume10
dc.relation.ispartofNORTHERN CLINICS OF ISTANBUL = ISTANBUL KUZEY KLINIKLERI
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectMedicine
dc.subjectHealth Sciences
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectClinical Medicine (MED)
dc.subjectCLINICAL MEDICINE
dc.titlePlasminogen Activator Inhibitor-1 Levels as an Indicator of Severity and Mortality for COVID-19
dc.typeArticle
dspace.entity.typePublication
local.avesis.idf22d6a74-3b19-4cc5-947f-917015b2774f
local.indexed.atPubMed
relation.isAuthorOfPublicationb1f9cb67-7168-4056-bbe8-ba075b9fca87
relation.isAuthorOfPublication.latestForDiscoveryb1f9cb67-7168-4056-bbe8-ba075b9fca87

Files